Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™ (nanoparticle reformulation of p...

Santarus, Inc. recently  announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study...

We know that, Linagliptin ( BI-1356 , trade name Tradjenta ) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of ...

Could new drug cure nearly any viral infection? Technology shows promise against common cold, influenza and other ailments, researchers say...

In continuation of my update on H.Pylori http://www.med-chemist.com/search?q=pylori .. We know that,  stomach bacterium Helicobacter pyl...

In continuation of my updates on Rivaroxaban ... FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research ...

In continuation of my update on fenretinide ... For more than two decades, researchers have studied and used fenretinide , a synthet...

In continuation of my update on vancomycin .... A team of scientists from The Scripps Research Institute has successfully reengineer...

New class of anti-diabetic compound established

In continuation of my update on Valproic acid... New research suggests brain tumor patients who take the seizure drug valproic acid on t...

In continuation of my update on the usefulness of   Casaicin... We know that, Capsicum annum contains capsaicin, which is the main com...

In continuation of my update on  Crizotinib ..... Press Announcements FDA approves Xalkori with companion diagnostic for a type of late-st...

A team of medical engineers headed by Prof. Bernhard Wolf at the TUM Heinz Nixdo rf Chair of Medical Electronics have now developed a sens...

Scientists Re-engineer an Antibiotic to Overcome Resistant Bacteria - Topix

Scientists at Yale University have developed the first practical method to create a compound called huperzine A  (see structure below) in ...